# Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLC

> **NCT00697333** · PHASE2 · UNKNOWN · sponsor: **Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN** · enrollment: 200 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **PROCEDURE:** restriction of radiotherapy to FDG-PET positive areas only

## Key facts

- **NCT ID:** NCT00697333
- **Lead sponsor:** Arbeitsgemeinschaft Nuklearmedizin und Strahlentherapie der DEGRO und DGN
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-05
- **Primary completion:** 2016-11
- **Final completion:** 2017-05
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2016-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00697333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00697333, "Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLC". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00697333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*